{
    "2018-12-05": [
        [
            {
                "time": "2018-03-27",
                "original_text": "Sensex Down Over 300 Points In Early Trade; Nifty Dips Below 10,700",
                "features": {
                    "keywords": [
                        "Sensex",
                        "Down",
                        "300 Points",
                        "Early Trade",
                        "Nifty",
                        "Dips",
                        "10,700"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "index"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-14",
                "original_text": "Roche's Tecentriq Combination Gets Priority Review by FDA",
                "features": {
                    "keywords": [
                        "Roche",
                        "Tecentriq",
                        "Priority Review",
                        "FDA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Incyte (INCY) Announces Positive Data on Jakafi for GVHD",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Positive Data",
                        "Jakafi",
                        "GVHD"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}